Churchill Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-43,931
Closed -$10.7M 115
2022
Q2
$10.7M Buy
43,931
+560
+1% +$137K 0.27% 51
2022
Q1
$10.5M Buy
+43,371
New +$9.96M 0.18% 61
2020
Q4
Sell
-11,427
Closed -$2.9M 130
2020
Q3
$2.9M Buy
+11,427
New +$2.83M 0.07% 104
2019
Q2
Sell
-127,125
Closed -$24.2M 106
2019
Q1
$24.2M Sell
127,125
-2,194
-2% -$419K 0.64% 18
2018
Q4
$25.2M Buy
129,319
+37,387
+41% +$7.29M 1.1% 10
2018
Q3
$19.1M Sell
91,932
-5,827
-6% -$1.15M 0.41% 34
2018
Q2
$18M Sell
97,759
-5,112
-5% -$904K 0.48% 36
2018
Q1
$17.5M Buy
+102,871
New +$18.9M 0.51% 34

Other funds holding AMGN

Churchill Management's AMGN Position: Q3 2022 in Review

Churchill Management sold out of Amgen (AMGN) in Q3 2022, closing a stake of 43,931 shares — an estimated $10.7M sold.

Churchill Management first reported a position in AMGN in Q1 2018 and held it in 8 quarters. The position peaked at $25.2M in Q4 2018. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

  • Churchill Management reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
  • Churchill Management sold 43,931 Amgen shares in Q3 2022, an estimated $10.7M.
  • Churchill Management first reported a position in Amgen in Q1 2018 and held it in 8 quarters.
  • Churchill Management's Amgen position peaked at $25.2M in Q4 2018.
  • 2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Churchill Management's 13F filing for Q3 2022, filed 11 Oct 2022.